A MECHANISTIC PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL TO PREDICT THE PHARMACOKINETICS OF R/S-OXAZEPAM AFTER ORAL DOSING

被引：0
|
作者：
Turner, David B. [1 ]
Pade, Devendra [1 ]
Jamei, Masoud [1 ]
Neuhoff, Sibylle [2 ]
机构：
[1] Simcyp Ltd, Modelling & Simulat, Sheffield, S Yorkshire, England
[2] Simcyp Ltd, Translat Sci DMPK, Sheffield, S Yorkshire, England
来源：
DRUG METABOLISM REVIEWS | 2015年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P388
引用
收藏
页码：221 / 222
页数：2
相关论文
共 50 条
  • [21] A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines
    Tegenge, Million A.
    Mitkus, Robert J.
    [J]. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2013, 40 (05) : 545 - 556
  • [22] A physiologically-based pharmacokinetic (PBPK) model of squalene-containing adjuvant in human vaccines
    Million A. Tegenge
    Robert J. Mitkus
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2013, 40 : 545 - 556
  • [23] Development of Physiologically-Based Pharmacokinetic (PBPK) model for biodistribution of radiolabeled peptides in human body
    Gospavic, R.
    Knoll, P.
    Mirzaei, S.
    Popov, V.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S342 - S342
  • [24] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODEL FOR ABSORPTION OF ORAL PARACETAMOL IN MAN
    CLEMENTS, JA
    NIMMO, WS
    HEADING, RC
    PRESCOTT, LF
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 1978, 30 : P60 - P60
  • [25] A physiologically-based pharmacokinetic (PBPK) and pharmacodynamic (PD) model of docetaxel (Doc) and neutropenia in humans
    Florian, J. A., Jr.
    Egorin, M. J.
    Zamboni, W. C.
    Eiseman, J. L.
    Lagattuta, T. F.
    Belani, C. P.
    Chatta, G. S.
    Scher, H. I.
    Solit, D. B.
    Parker, R. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [26] VARIABILITY OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL PARAMETERS AND THEIR EFFECTS ON PBPK MODEL PREDICTIONS IN A RISK ASSESSMENT FOR PERCHLOROETHYLENE (PCE)
    GEARHART, JM
    MAHLE, DA
    GREENE, RJ
    SECKEL, CS
    FLEMMING, CD
    FISHER, JW
    CLEWELL, HJ
    [J]. TOXICOLOGY LETTERS, 1993, 68 (1-2) : 131 - 144
  • [27] PHYSIOLOGICALLY-BASED PHARMACOKINETIC MODELING (PBPK) OF PITAVASTATIN AND ATORVASTATIN TO PREDICT DRUG-DRUG INTERACTIONS (DDIS).
    Duan, P.
    Zhao, P.
    Zhang, L.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 97 : S16 - S17
  • [28] APPLICATION OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODEL IN PREDICTING DRUG METABOLISM AND PHARMACOKINETICS IN PEDIATRIC POPULATIONS - A CASE STUDY OF ACETAMINOPHEN.
    Jiang, X.
    Zhao, P.
    Lesko, L. J.
    Schmidt, S.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S50 - S50
  • [29] Physiologically-based pharmacokinetic (PBPK) model to predict IgG tissue kinetics in wild-type and FcRn-knockout mice
    Garg A.
    Balthasar J.P.
    [J]. Journal of Pharmacokinetics and Pharmacodynamics, 2007, 34 (5) : 687 - 709
  • [30] Prediction of pharmacokinetic parameters of inhaled indacaterol formulation in healthy volunteers using physiologically-based pharmacokinetic (PBPK) model
    Tang, Cui
    Ou-yang, Chen-xi
    Chen, Wen-jing
    Zou, Chan
    Huang, Jie
    Cui, Chang
    Yang, Shuang
    Guo, Can
    Yang, Xiao-yan
    Lin, Yu
    Pei, Qi
    Yang, Guo-ping
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 168
12345